Advertisement
Vanda Pharmaceuticals Inc. (VNDA)
NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Follow
As of 03:38PM EST. Market open.
| Previous Close | 4.89 |
| Open | 4.80 |
| Bid | 4.97 x 100 |
| Ask | 5.01 x 200 |
| Day's Range | 4.80 - 5.30 |
| 52 Week Range | 3.30 - 6.75 |
| Volume | |
| Avg. Volume | 574,581 |
| Market Cap | 291.74M |
| Beta (5Y Monthly) | N/A |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.19 |
| Earnings Date | Feb 05, 2025 - Feb 10, 2025 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 10.55 |
GuruFocus.comVanda Pharmaceuticals Inc (VNDA) Q3 2024 Earnings Call Highlights: Revenue Surge Amidst Rising ...
Vanda Pharmaceuticals Inc (VNDA) reports a 23% revenue increase in Q3 2024, driven by Fanapt sales, despite a net loss and increased operating expenses.
- Associated Press Finance
Vanda: Q3 Earnings Snapshot
WASHINGTON (AP) — Vanda Pharmaceuticals Inc. VNDA) on Wednesday reported a loss of $5.3 million in its third quarter. The Washington-based company said it had a loss of 9 cents per share.
Advertisement
Advertisement
Advertisement
© 2024 Yahoo. All rights reserved.